132 related articles for article (PubMed ID: 7518781)
1. Long-acting somatostatin analogue therapy and protein metabolism in patients with jejunostomies.
O'Keefe SJ; Haymond MW; Bennet WM; Oswald B; Nelson DK; Shorter RG
Gastroenterology; 1994 Aug; 107(2):379-88. PubMed ID: 7518781
[TBL] [Abstract][Full Text] [Related]
2. Octreotide as an adjunct to home parenteral nutrition in the management of permanent end-jejunostomy syndrome.
O'Keefe SJ; Peterson ME; Fleming CR
JPEN J Parenter Enteral Nutr; 1994; 18(1):26-34. PubMed ID: 8164299
[TBL] [Abstract][Full Text] [Related]
3. Effect of parenteral amino acids on human pancreatic exocrine secretion.
Variyam EP; Fuller RK; Brown FM; Quallich LG
Dig Dis Sci; 1985 Jun; 30(6):541-6. PubMed ID: 2581745
[TBL] [Abstract][Full Text] [Related]
4. The influence of intravenous infusions of glucose and amino acids of pancreatic enzyme and mucosal protein synthesis in human subjects.
O'Keefe SJ; Lemmer ER; Ogden JM; Winter T
JPEN J Parenter Enteral Nutr; 1998; 22(5):253-8. PubMed ID: 9739026
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects.
Harris AG
Gut; 1994; 35(3 Suppl):S1-4. PubMed ID: 7911441
[TBL] [Abstract][Full Text] [Related]
6. Trypsin and splanchnic protein turnover during feeding and fasting in human subjects.
O'keefe SJ; Lee RB; Li J; Zhou W; Stoll B; Dang Q
Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G213-21. PubMed ID: 16123201
[TBL] [Abstract][Full Text] [Related]
7. Effects of intravenous infusion of amino acids, fat, or glucose on unstimulated pancreatic secretion in healthy humans.
Niederau C; Sonnenberg A; Erckenbrecht J
Dig Dis Sci; 1985 May; 30(5):445-55. PubMed ID: 2580678
[TBL] [Abstract][Full Text] [Related]
8. Lack of inhibitory effect of octreotide on intestinal adaptation in short bowel syndrome in the rat.
Vanderhoof JA; Kollman KA
J Pediatr Gastroenterol Nutr; 1998 Mar; 26(3):241-4. PubMed ID: 9523855
[TBL] [Abstract][Full Text] [Related]
9. Effect of octreotide, a long-acting somatostatin analogue, on plasma amino acid uptake by the pancreas.
Gullo L; Pezzilli R; Ancona D; Labate AM; Barbara L
Pancreas; 1991 Nov; 6(6):668-72. PubMed ID: 1780327
[TBL] [Abstract][Full Text] [Related]
10. Effect of a long acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome.
Ladefoged K; Christensen KC; Hegnhøj J; Jarnum S
Gut; 1989 Jul; 30(7):943-9. PubMed ID: 2668129
[TBL] [Abstract][Full Text] [Related]
11. Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men.
Lembcke B; Creutzfeldt W; Schleser S; Ebert R; Shaw C; Koop I
Digestion; 1987; 36(2):108-24. PubMed ID: 2883060
[TBL] [Abstract][Full Text] [Related]
12. Effects of somatostatin on exocrine and endocrine pancreatic function stimulated by intestinal hormones in man.
Dollinger HC; Raptis S; Pfeiffer EF
Horm Metab Res; 1976 Jan; 8(1):74-8. PubMed ID: 765255
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic effects of Sandostatin in the gastrointestinal tract.
Gyr KE; Meier R
Metabolism; 1992 Sep; 41(9 Suppl 2):17-21. PubMed ID: 1518430
[TBL] [Abstract][Full Text] [Related]
14. The effects of octreotide, soy polysaccharide, codeine and loperamide on nutrient, fluid and electrolyte absorption in the short-bowel syndrome.
Rodrigues CA; Lennard-Jones JE; Thompson DG; Farthing MJ
Aliment Pharmacol Ther; 1989 Apr; 3(2):159-69. PubMed ID: 2491467
[TBL] [Abstract][Full Text] [Related]
15. Review article: practical management of the short bowel.
Lennard-Jones JE
Aliment Pharmacol Ther; 1994 Dec; 8(6):563-77. PubMed ID: 7696444
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the 'colonic brake' to gastric emptying.
Nightingale JM; Kamm MA; van der Sijp JR; Ghatei MA; Bloom SR; Lennard-Jones JE
Gut; 1996 Aug; 39(2):267-72. PubMed ID: 8977342
[TBL] [Abstract][Full Text] [Related]
17. Impaired pancreatic secretion in severely malnourished patients is a consequence of primary pancreatic dysfunction.
Winter TA; Marks T; Callanan M; O'Keefe SJ; Bridger S
Nutrition; 2001 Mar; 17(3):230-5. PubMed ID: 11312065
[TBL] [Abstract][Full Text] [Related]
18. [The role of long-acting release (LAR) depot octreotide as adjuvant management of short bowel disease].
Gómez-Herrera E; Farías-Llamas OA; Gutiérrez-de la Rosa JL; Hermosillo-Sandoval JM
Cir Cir; 2004; 72(5):379-86. PubMed ID: 15550227
[TBL] [Abstract][Full Text] [Related]
19. Effect of ileal infusion of short-chain fatty acids on pancreatic prandial secretion and gastrointestinal hormones in pigs.
Sileikiene V; Mosenthin R; Bauer E; Piepho HP; Tafaj M; Kruszewska D; Weström B; Erlanson-Albertsson C; Pierzynowski SG
Pancreas; 2008 Aug; 37(2):196-202. PubMed ID: 18665083
[TBL] [Abstract][Full Text] [Related]
20. Impaired gastric acid and pancreatic enzyme secretion in patients with Crohn's disease may be a consequenece of a poor nutritional state.
Winter TA; O'keefe SJ; Callanan M; Marks T
Inflamm Bowel Dis; 2004 Sep; 10(5):618-25. PubMed ID: 15472524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
